| NDC Code | 60687-765-13 |
|---|
| Package Description | 1 BOTTLE, GLASS in 1 CARTON (60687-765-13) / 100 mL in 1 BOTTLE, GLASS |
|---|
| Product NDC | 60687-765 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Valganciclovir |
|---|
| Non-Proprietary Name | Valganciclovir Hydrochloride |
|---|
| Dosage Form | POWDER, FOR SOLUTION |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20230820 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA211475 |
|---|
| Manufacturer | American Health Packaging |
|---|
| Substance Name | VALGANCICLOVIR HYDROCHLORIDE |
|---|
| Strength | 50 |
|---|
| Strength Unit | mg/mL |
|---|
| Pharmacy Classes | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT] |
|---|